ANG and type 2 diabetes mellitus: Notably, plasma angiogenin was associated with 2.35-fold risk of MACE (multivariable adjusted ,95% CI 1.01–5.43) in T2D patients with normal kidney function (eGFR > 90 ml/min/1.73m2) at baseline (Supplementary Table S5).